Insurance Coverage: Many major insurance plans no longer cover Invokana starting in 2016. Learn More
The GoodRx Pharmacist - July 06, 2016
According to the FDA, canagliflozin and dapagliflozin may cause an increased risk of acute kidney injury. The previous warning for canagliflozin was for an increased risk of foot and leg amputations—all serious stuff. See More
The GoodRx Pharmacist - June 08, 2016
The FDA has issued a safety alert for medications containing canagliflozin, a newer drug used to treat type 2 diabetes.
Do diabetics already have an increased risk of leg and foot amputations?
Yes. Diabetics have a higher risk of leg and foot amputations compared to a person who does not have diabetes. See More
Elizabeth Davis - August 12, 2015
It’s that time again—the new lists of covered and excluded drugs on next year’s insurance plans are out, and it doesn’t look great. For many Americans with health insurance, more than 50 popular brand-name and generic drugs may no longer be covered starting in January 2016.
Express Scripts and Caremark, companies that handles pharmacy benefits for more than 200 million Americans, are removing about 20 – 30 drugs each from their national preferred formularies at the end of 2015. See More
The GoodRx Pharmacist - May 21, 2015
On May 15, 2015, the FDA issued a warning for the newest class of diabetes medications, SGLT2 inhibitors.
According to the FDA, the medications in this class may lead to a serious and life-threatening condition known as ketoacidosis.
Which medications are considered SGLT2 inhibitors?
These medications also contain SGLT2 inhibitors in combination with other active ingredients:
- Glyxambi (empagliflozin/linagliptin)
- Invokamet (canagliflozin/metformin)
- Xigduo XR (dapagliflozin/metformin)
What should I do if I am taking one of these medications?
If you are taking one of the medications listed above DO NOT stop your medication without talking to your doctor. See More
Dr. Sharon Orrange - September 30, 2014
Invokana (canagliflozin) is one of the new oral medications for adult onset diabetes. It’s expensive but has many upsides. Taken usually in combination with metformin it is a rising star in the treatment of diabetes. Here is what you need to know to help you decide: worth it or not?
The GoodRx Pharmacist - August 08, 2014
Jardiance (empagliflozin) was approved by the FDA on August 1, 2014 for the treatment of type 2 diabetes.
How does Jardiance work?
It works with the body’s natural process of urination to help remove more excess sugar from the body rather than allowing it to be reabsorbed by your kidneys. See More
The GoodRx Pharmacist - January 10, 2014
Farxiga (dapagliflozin) was approved by the FDA for the treatment of type II diabetes this week, after a previous denial in January 2012 due to bladder cancer concerns. Here’s what you need to know:
How does Farxiga work, and are there any similar drugs available?
Dapagliflozin is part of a newer class of drugs: Sodium Glucose Co-Transporter 2 inhibitors (SGLT2 inhibitors). Invokana (canagliflozin), approved in March 2013, is the only other medication in this class. See More
The GoodRx Pharmacist - December 31, 2013
In a non-diabetic person, insulin is released from the pancreas with each meal and it helps the body either use or store the glucose it gets from the food. Patients who have type I diabetes don’t produce insulin, and must inject themselves with insulin to mimic the body’s natural process.
Type II diabetics, on the other hand, still produce insulin but their bodies do not use it properly. Type II diabetics can be treated with oral medications, insulin, other injectables, or a combination of different medications. See More
The GoodRx Pharmacist - July 25, 2013
Invokana (canaglifozin) is now readily available at most pharmacies after receiving approval for the treatment of type 2 diabetes earlier this year. Here’s what you need to know.
What is Invokana?
Type 2 diabetes leads to elevated levels of glucose in the blood, because of the inability of your body either to make enough insulin or because your cells cannot use it properly. Invokana is a novel drug that works by blocking glucose from being reabsorbed by the kidney. See More